Exhibitors Search
Darae Strategy&Business Center
|
Exhibition
|
|
|---|---|
|
Booth no.
|
G25 |
|
Country
|
Korea, South |
|
Address
|
132 Teheran-ro, Gangnam-gu, Seoul, Republic of Korea |
|
Tel
|
<02-3475-7774 |
|
Exhibits
|
피부장벽 메커니즘 기반의 신규 펩타이드(차의과대학교), Pediococcus SY23 관절염 프로바이오틱스, Lactobacillus buchneri 200793 항우울 조성물, Lactococcus lactis KC24 수면장애 조성물, 3D 줄기세포 엑소좀 신경재생·통증 완화, 소변 DNA 기반 방광암 조기진단, 브랜치드 하이드록시산 대사질환 조절, 탈모·발모·피부재생 조성물, 인삼 유래 진토닌 안질환·탈모 조성물, 건성 황반변성 후보물질, 패혈증성 신손상 개선 천연물, 분자진단용 분할 T7 프로모터, 3D 배양육 바이오잉크, 단백질 환형화 기술, 대장암 압타머 진단·치료 기술(이상 건국대학교) |
|
Company Type
|
Exhibitor Information
1. R&D x IP Service - IP Strategic Consulting, R&D Planning, Public funded R&D Planning & Evaluation / Policy Research
2. Accelerating - Accelerating, Investment, Company Building
3. Patent·IP Valuation - Advanced Valuation of Patents and Technologies, Simple Patent & Technology Valuation, Valuation by Technology Level (TCB)
4. Tech Commercialization - Technology Marketing (Tech Transfer), Business Modeling (BM)
5. International Collaborative Research (Horizon Europe)
2. Accelerating - Accelerating, Investment, Company Building
3. Patent·IP Valuation - Advanced Valuation of Patents and Technologies, Simple Patent & Technology Valuation, Valuation by Technology Level (TCB)
4. Tech Commercialization - Technology Marketing (Tech Transfer), Business Modeling (BM)
5. International Collaborative Research (Horizon Europe)
Exhibit/Technology Introduction (General)
This portfolio includes novel peptides targeting skin barrier mechanisms from CHA University, 3D stem cell-derived exosomes for neural regeneration and pain relief, urinary DNA-based early diagnosis of bladder cancer, branched-chain hydroxy acid metabolism regulators for metabolic disorders, drug candidates for dry age-related macular degeneration, natural compounds for sepsis-induced kidney injury, split T7 promoter technology for molecular diagnostics, protein cyclization technology, and aptamer-based diagnostics and therapeutics for colorectal cancer from Konkuk University.
Individual Exhibit/Technology Introduction (Detailed)
-
Product Name : Therapeutic Composition Containing 3D Stem Cell-derived Exosomes for Neurodegenerative Disease ImprovementThis therapeutic composition employs exosomes derived from 3D-cultured human umbilical cord stem cells, providing enhanced yield, purity, and functional efficacy compared to 2D methods. It promotes neuroregeneration, pain relief, and axonal repair, offering an advanced treatment for neuropathic pain and neurodegenerative diseases.
-
Product Name : Early Bladder Cancer Diagnosis and Screening Using Cell Pellet DNA from UrineThis diagnostic method uses urine-derived cell pellet DNA (cpDNA) as a biomarker for early bladder cancer detection. It demonstrates strong genomic concordance with tumor DNA, providing a non-invasive, cost-effective, and highly accurate alternative to cystoscopy with potential for clinical adoption.
-
Product Name : Gut Microbiota Modulation by Branched-Chain Hydroxy Acids for Health ImprovementBranched-chain hydroxy acids (BCHAs) selectively promote beneficial gut bacteria and inhibit pathogenic strains, restoring microbiota balance. They act as natural antibiotic alternatives with applications in gut health, immunity, and metabolic disorder management, making them suitable for functional foods and nutraceuticals.
-
Product Name : Novel Peptides for Skin Barrier FunctionThe novel peptides enhance skin barrier function by targeting tight junction proteins and promoting intercellular adhesion between epidermal cells, leading to wrinkle reduction, enhanced skin elasticity, alleviation of pruritus, and inhibition of rosacea and angiogenesis.
-
Product Name : Hair Loss Prevention and Treatment Composition Containing Keratinocyte-derived Decellularized ECMThis composition incorporates keratinocyte-derived decellularized extracellular matrix (HaCaT-ECM), enhancing hair follicle cell proliferation and regulating hair growth cycle genes. Safer than finasteride or minoxidil, it stimulates hair regeneration and skin repair, offering a versatile platform for cosmetics and wound healing.
-
Product Name : Pharmaceutical Composition Containing Keratin 8 Phosphorylation Inhibitor for AMD Prevention and TreatmentThis therapeutic approach suppresses keratin 8 phosphorylation and rearrangement under oxidative stress, preventing retinal degeneration in dry AMD. Using trametinib, an ERK inhibitor, it demonstrated lesion reduction and represents the first oral candidate treatment for dry macular degeneration.
-
Product Name : Composition Containing Biochanin A for Prevention and Treatment of Sepsis-associated Acute Kidney InjuryThis composition utilizes Biochanin A, a natural isoflavone, to inhibit HMGB1 release and ferroptosis, key drivers of septic acute kidney injury. It improves survival, kidney function, and reduces organ damage, offering a novel therapeutic or nutraceutical solution for sepsis-induced AKI.
-
Product Name : Split T7 Promoter-based Isothermal Single Enzyme Probe Set for Molecular DiagnosticsThis one-pot molecular diagnostic system leverages split T7 promoters that activate transcription only in target presence, enabling rapid, highly specific detection at 37°C within 30 minutes. It minimizes false positives and supports multiplex analysis, applicable to pathogens, mutations, and biomarkers.
-
Product Name : Recombinant Vector System for Enhanced Stability Circular Protein ProductionThis recombinant vector system employs split inteins for in-cell cyclization of proteins, producing highly stable and degradation-resistant circular proteins. It achieves near 100% efficiency, enhancing durability and expanding applications in therapeutics, diagnostics, industrial enzymes, and nanobiotechnology.
-
Product Name : Colorectal Cancer Cell-specific Aptamer for Diagnostic and Therapeutic ApplicationsThis technology identifies highly specific aptamers binding to all colorectal cancer stages via CROSS-SELEX, avoiding cross-reactivity with normal cells. Applicable in early diagnosis, fluorescent probes, and targeted drug delivery, it enhances efficacy and safety over antibody-based approaches.

KYUNGYON EXHIBITION CORP.